470 related articles for article (PubMed ID: 22238919)
1. [Botulinum toxin treatment in children].
Sätilä H; Vähäsarja V; Paavilainen P
Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
[TBL] [Abstract][Full Text] [Related]
2. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
5. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.
Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A
J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
Sätilä H; Huhtala H
Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
12. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
Langdon K; Blair E; Davidson SA; Valentine J
Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
[No Abstract] [Full Text] [Related]
13. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
Kwon JY; Hwang JH; Kim JS
Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
[TBL] [Abstract][Full Text] [Related]
14. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
15. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
Bennett D; Walsh M; O'Sullivan R; Gallagher J; O'Brien T; Newman CJ
J Pediatr Orthop; 2007; 27(3):288-94. PubMed ID: 17414011
[TBL] [Abstract][Full Text] [Related]
16. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
17. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
19. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
Sätilä HK; Pietikäinen T; Lehtonen-Räty P; Koivikko M; Autti-Rämö I
Neuropediatrics; 2006 Dec; 37(6):344-9. PubMed ID: 17357036
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]